Craneware (CRW) Share Price, News & Analysis

Company Overview

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

Key Stats

• Today's Range: 1,109.30 to 1,167.32
• 50-Day Range: 1,098 to 1,589.69
• 52-Week Range: 988 to 2,644
• Volume: 429,451 shs
• Average Volume: 287,447 shs
• Market Capitalization: £387.95 million
• P/E Ratio: 18.01
• Dividend Yield: 3.02%
• Price Target: GBX 2,222.75
• Consensus Rating: Buy

Craneware Stock Analysis - MarketRank™

Craneware scored higher than 92% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Craneware has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Craneware has a consensus price target of GBX 2,222.75, representing about 96.2% upside from its current price of GBX 1,133.13.

Amount of Analyst Coverage

Craneware has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Craneware is 18.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 46.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of Craneware is 18.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.42.

Price to Book Value per Share Ratio

Craneware has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CRW.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Craneware pays a meaningful dividend of 3.02%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Craneware does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Craneware is 66.71%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 1.36

News Sentiment

Craneware has a news sentiment score of 1.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Craneware this week, compared to 0 articles on an average week.

Search Interest

Only 2 people have searched for CRW on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 4.4 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of Craneware in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net £107,502.68 in company stock, which represents 0.0277% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Craneware insiders have bought more of their company's stock than they have sold. Specifically, they have bought £107,502.68 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

10.30% of the stock of Craneware is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

36.52% of the stock of Craneware is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: LON:CRW
• CIK: N/A
• Web: public.craneware.com
• Phone: +44-131-5503100
• Fax: N/A
• Employees: 734
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Craneware: GBX 2,222.75
• High Price Target: GBX 2,871
• Low Price Target: GBX 570
• Potential Upside/Downside: +96.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 62.90
• Trailing P/E Ratio: 18.01
• Forward P/E Ratio: 14.42
• P/E Growth: N/A
• Net Income: £14.27 million
• Net Margins: 10.63%
• Pretax Margin: N/A
• Return on Equity: 6.65%
• Return on Assets: 2.28%

Debt

• Debt-to-Equity Ratio: 7.93
• Current Ratio: 0.76
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: £211.33 million
• Price / Sales: 1.84
• Cash Flow: GBX 77 per share
• Price / Cash Flow: 14.72
• Book Value: GBX 932.46 per share
• Price / Book: 1.22

Miscellaneous

• Outstanding Shares: 34,237,000
• Free Float: N/A
• Market Cap: £387.95 million
• Optionable: Not Optionable
• Beta: 0.28